Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Ken W who wrote (4172)	1/7/2004 11:51:01 PM
From: PuddleGlum	Read Replies (2) \| Respond to of 23958

Hey, neighbor, I thought I'd weigh in on STEM: stockcharts.com[PA][DA][F!3!2.0!]&pref=G P&F wise it needs to go through 2.40 to head higher, though the bearish resistance line, and therefore the breakout point, will drop if we get some backing and filling in the near term. GERN and some gene therapy companies such as TLRK, SGMO, and ARIA have more substance to them than STEM, I think. Not that GERN and ARIA haven't been accused of blowing smoke a few times... TLRK is a blue sky breakout now, while SGMO is still fighting some resistance around 5.80. ARIA has a court date with LLY next week that could really send ARIA flying (unless the court clips the wings). GERN has bottomed and is in good position to move up. There's a major biotech conference next week, and the biotech sector looks like it wants to break out of a long consolidation period. And that will be good for STEM, as well, so your suggestion doesn't have all that much downside in this environment. Another stem cell type of play is CRXL. It gapped up today, but that one has a fire under it, I think.